DC Chemicals

All products / DC10418

PF-04957325
CAT. NO. DC10418

PF-04957325

Pack sizes and prices

Pack sizePrice
100 mg$900 USDRequest a quote →
250 mg$1,800 USDRequest a quote →
1 g$3,600 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

PF-04957325 is over two orders of magnitude less efficient than PICL in suppressing polyclonal Teff cell proliferation, and shows no effect on cytokine gene expression in these cells, despite its robust effect on T cell adhesion. PF-04957325 is a selective PDE8 inhibitor and inhibits breast cancer cell migration. PF-04957325 greatly potentiates steroidogenesis in WT adrenal cells. PF-04957325 shows a reported IC50 of 0.7 nM against PDE8A, 0.2 nM against PDE8B, and > 1.5 μM against all other PDE isoforms. PF-04957325 treatment of WT Leydig cells or MA10 cells increases steroid production but has no effect in PDE8A (-/-)/B(-/-) double-knockout cells, confirming the selectivity of the drug. Moreover, under basal conditions, cotreatment with PF-04957325 plus rolipram, a PDE4-selective inhibitor, synergistically potentiates steroid production.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC10418
Product namePF-04957325
CAS1305115-80-3
Molecular formulaC14H15F3N8OS
Molecular weight400.38
Purity>98%
SMILESNC1=C(N=NN2C[C@H]3CN(CC4=NC=CS4)CCO3)C2=NC(C(F)(F)F)=N1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — PF-04957325 (DC10418)

Related research products